Partly out of interest in the company and partly because the share price is so much lower now than when I sold the stock, I’ve been looking at Knight Therapeutics and writing a new post about it. To provide a bit of context for that post, I thought I should repost this and another old Knight post. This post about Jonathan Goodman does as good a job as anything explaining why I remain interested in Knight despite its performance. I believe you could expect the new Knight Therapeutics article on Monday, and the other old Knight article later today. Thanks as always for reading and supporting.
Jonathan Goodman: A Canadian Outsider CEO
Jonathan Goodman: A Canadian Outsider CEO
Jonathan Goodman: A Canadian Outsider CEO
Partly out of interest in the company and partly because the share price is so much lower now than when I sold the stock, I’ve been looking at Knight Therapeutics and writing a new post about it. To provide a bit of context for that post, I thought I should repost this and another old Knight post. This post about Jonathan Goodman does as good a job as anything explaining why I remain interested in Knight despite its performance. I believe you could expect the new Knight Therapeutics article on Monday, and the other old Knight article later today. Thanks as always for reading and supporting.